These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26212520)

  • 21. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
    Zaslavsky BG
    Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Null Hypotheses, Interval Estimation, and Bayesian Analysis.
    Shin JJ; Zurakowski D
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):919-920. PubMed ID: 29192854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of issues about null hypothesis Bayesian testing.
    Tendeiro JN; Kiers HAL
    Psychol Methods; 2019 Dec; 24(6):774-795. PubMed ID: 31094544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Détente: A Practical Understanding of P values and Bayesian Posterior Probabilities.
    Ruberg SJ
    Clin Pharmacol Ther; 2021 Jun; 109(6):1489-1498. PubMed ID: 32748400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the P Value Have a Future in Plant Pathology?
    Madden LV; Shah DA; Esker PD
    Phytopathology; 2015 Nov; 105(11):1400-7. PubMed ID: 26325004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decision qualities of Bayes factor and p value-based hypothesis testing.
    Jeon M; De Boeck P
    Psychol Methods; 2017 Jun; 22(2):340-360. PubMed ID: 28594227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2004 Jun; 43(11):1929-39. PubMed ID: 15172393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three Insights from a Bayesian Interpretation of the One-Sided
    Marsman M; Wagenmakers EJ
    Educ Psychol Meas; 2017 Jun; 77(3):529-539. PubMed ID: 29795927
    [No Abstract]   [Full Text] [Related]  

  • 29. Bayesian hypothesis testing-use in interpretation of measurements.
    Miller G; Martz H; Little T; Bertelli L
    Health Phys; 2008 Mar; 94(3):248-54. PubMed ID: 18301098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic statistics for clinicians: 1. Hypothesis testing.
    Guyatt G; Jaeschke R; Heddle N; Cook D; Shannon H; Walter S
    CMAJ; 1995 Jan; 152(1):27-32. PubMed ID: 7804919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis testing.
    Yarandi HN
    Clin Nurse Spec; 1996 Jul; 10(4):186-8. PubMed ID: 8900794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misinterpreting p: The discrepancy between p values and the probability the null hypothesis is true, the influence of multiple testing, and implications for the replication crisis.
    Anderson SF
    Psychol Methods; 2020 Oct; 25(5):596-609. PubMed ID: 31829657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. fbst: An R package for the Full Bayesian Significance Test for testing a sharp null hypothesis against its alternative via the e value.
    Kelter R
    Behav Res Methods; 2022 Jun; 54(3):1114-1130. PubMed ID: 34471963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementing the P-value from null-hypothesis significance testing with a Bayes factor from null-hypothesis Bayesian testing.
    Malone HE; Coyne I
    Nurse Res; 2020 Nov; ():. PubMed ID: 33150776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The flaw of averages: Bayes factors as posterior means of the likelihood ratio.
    Liu CC; Yu RX; Aitkin M
    Pharm Stat; 2024; 23(4):466-479. PubMed ID: 38282048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model-averaging approach to replication: the case of p rep.
    Iverson GJ; Wagenmakers EJ; Lee MD
    Psychol Methods; 2010 Jun; 15(2):172-81. PubMed ID: 20515238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing normal means: the reconcilability of the P value and the Bayesian evidence.
    Yin Y; Zhao J
    ScientificWorldJournal; 2013; 2013():381539. PubMed ID: 24307867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Worked-out examples of the adequacy of Bayesian optional stopping.
    Tendeiro JN; Kiers HAL; van Ravenzwaaij D
    Psychon Bull Rev; 2022 Feb; 29(1):70-87. PubMed ID: 34254263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving Inferences About Null Effects With Bayes Factors and Equivalence Tests.
    Lakens D; McLatchie N; Isager PM; Scheel AM; Dienes Z
    J Gerontol B Psychol Sci Soc Sci; 2020 Jan; 75(1):45-57. PubMed ID: 29878211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting and interpretation in genome-wide association studies.
    Wakefield J
    Int J Epidemiol; 2008 Jun; 37(3):641-53. PubMed ID: 18270206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.